18:53:39 EST Mon 09 Feb 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Cronos Group Inc
Symbol CRON
Shares Issued 385,681,863
Close 2025-06-23 C$ 2.55
Market Cap C$ 983,488,751
Recent Sedar+ Documents

Cronos shareholders elect seven directors at AGM

2025-06-23 20:05 ET - News Release

Mr. Harrison Aaron reports

CRONOS GROUP INC. ANNOUNCES RESULTS OF 2025 ANNUAL MEETING OF SHAREHOLDERS

At Cronos Group Inc.'s annual meeting of shareholders held on Friday, June 20, 2025, shareholders holding a total of 276,989,452 common shares of the company voted in person or by proxy, representing 71.87 per cent of the total number of common shares of the company outstanding.

Each of the directors listed as a nominee in the company's definitive proxy statement dated April 25, 2025, was elected as a director of the company, with each director receiving in excess of 92.3 per cent of the votes cast in favour of his or her election. The detailed results of the vote for the election of directors are as follows.

Shareholders also approved an advisory (non-binding) resolution on the compensation of the company's named executive officers, with 94.13 per cent of votes cast in favour of such resolution, and approved the appointment of Davidson & Company LLP as the company's independent auditor for fiscal year 2025, and authorized the board of directors of the company to fix the independent auditor's remuneration.

For complete results on all matters voted on at the meeting, please see the report of voting results filed on the company's SEDAR+ profile and the company's Form 8-K filed on EDGAR.

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos's diverse international brand portfolio includes Spinach, Peace Naturals and Lord Jones.

© 2026 Canjex Publishing Ltd. All rights reserved.